University of California, Berkeley-Haas set. In an industry rife with collapse, Proteolix, a biotechnology company, was a rare accomplishment. The Proteolix case provides a powerful instance of a biotech company which has selected a "me-too" strategy, a less risky strategy than the strategy of detecting a drug for a novel objective. Nevertheless, even me-too drug strategies in the biotech industry face an uphill battle.
The protagonist, Susan Molineaux, along with her team, faced many challenges along the way and also the case study provides students with a map of some of her key choices at important points in the history of the company. The case study asks students to assess Molineaux's and her team's decisions and to identify the drivers of succeeding of the company's. The Proteolix case additionally enables pupils to get the biotechnology sector, its exceptional challenges, and also the particular challenges facing a me-too drug company that's attempting to dislodge a drug to treat life-threatening indicators."
Proteolix A Me-Too Success Case Study Solution
PUBLICATION DATE: August 01, 2012 PRODUCT #: B5719-HCB-ENG
This is just an excerpt. This case is about INNOVATION & ENTREPRENEURSHIP
Related Case Solutions & Analyses:
Atlantic Corporation – Abridged
Benchmarking Globalization to Boost Business Connections
Five Pillars for Doing Business in Africa: A Roadmap to Opportunities
The Sino-Russian Rapprochement: Energy Relations in a New Era
Term Sheet Negotiations: A “Rich-vs.-King” Approach
GM Hungary
North American Free Trade Agreement: Free For Whom?
Reconstruction of Zambia
Managing Mergers: Why People First Can Improve Brand and IT Consolidations
Shareholder Activism: This Changes Everything!
